Comparison of clinical characteristics of patients with acute kidney injury after intravenous versus inhaled colistin therapy

Conclusion The incidence of AKI in patient with colistin therapy is 60% in our center. It seems that inhaled colistin therapy could not be better in safety than intravenous colistin therapy.
Source: Kidney Research and Clinical Practice - Category: Urology & Nephrology Source Type: research